Vanguard Personalized Indexing Management, LLC Tg Therapeutics, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$6.09 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 23, 2022	SELL	$15.2 - $35.51 $163,096 - $381,022	-10,730 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$21.78 - $40.45 $233,699 - $434,028	10,730 New	10,730 $357,000

Others Institutions Holding TGTX

# of Institutions

337

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$444 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$329 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$263 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$103 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$92.6 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.2B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account